Coronavirus: Potential Drug Treatment Starts UK Trials

Coronavirus: Potential Drug Treatment Starts UK Trials

A drug that could help treat coronavirus is to be trialled on a small number of patients in England and Scotland.

The studies, which have been fast-tracked by the government, will initially involve 15 NHS centres.

In the absence of a known treatment for the virus, a handful of experimental drugs are being tested globally.

The drug, known as remdesivir, is manufactured by the pharmaceutical company Gilead.

Two studies are to be carried out in the UK - one on patients with moderate symptoms, and one on those who are in a serious condition.

Trials are already underway in China and the US, with the first results expected in the coming weeks.




Century-Old Tuberculosis Vaccine Eyed in Fight Against Coronavirus

Every Vaccine and Treatment in Development for COVID-19, So Far

Last Modified : January 11, 2022

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 22, 2024 at 12:50pm